Product NDC: | 43689-0009 |
Proprietary Name: | Tinnitus Relief |
Non Proprietary Name: | Calcarea Carbonica, Chininum Sulphuricum, Kali Carbonicum, Lycopodium Clavatum, Salicylicum Acidum |
Active Ingredient(s): | 6; 6; 6; 6; 6 [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1 & nbsp; Calcarea Carbonica, Chininum Sulphuricum, Kali Carbonicum, Lycopodium Clavatum, Salicylicum Acidum |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 43689-0009 |
Labeler Name: | The Magni Company |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | |
Marketing Category: | UNAPPROVED HOMEOPATHIC |
Start Marketing Date: | 20120816 |
Package NDC: | 43689-0009-1 |
Package Description: | 125 TABLET in 1 BOTTLE (43689-0009-1) |
NDC Code | 43689-0009-1 |
Proprietary Name | Tinnitus Relief |
Package Description | 125 TABLET in 1 BOTTLE (43689-0009-1) |
Product NDC | 43689-0009 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Calcarea Carbonica, Chininum Sulphuricum, Kali Carbonicum, Lycopodium Clavatum, Salicylicum Acidum |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20120816 |
Marketing Category Name | UNAPPROVED HOMEOPATHIC |
Labeler Name | The Magni Company |
Substance Name | LYCOPODIUM CLAVATUM SPORE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; POTASSIUM CARBONATE; QUININE SULFATE; SALICYLIC ACID |
Strength Number | 6; 6; 6; 6; 6 |
Strength Unit | [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1 |
Pharmaceutical Classes |